<DOC>
	<DOCNO>NCT01714960</DOCNO>
	<brief_summary>- To assess safety tolerability repeat dose topical administration MRZ-99030 Ophthalmic Solution ascend dos healthy subject ( stage 1 ) glaucoma subject ( stage 2 ) . - To assess plasma pharmacokinetics urine concentration MRZ- 99030 metabolite MRZ-9499 single repeat dose topical administration MRZ-99030 Ophthalmic Solution .</brief_summary>
	<brief_title>Safety Tolerability MRZ-99030 Eye Drops Healthy Volunteers Glaucoma Patients</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>For stage 1 : Healthy volunteer For stage 2 : Glaucoma patient For stage 2 : Any relevant eye disease glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>